Titan Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	55.58	32.86	48.64	68.14	54.51
Cash & Short-Term Investments	35.99	55.58	32.86	48.64	68.14	54.51
Cash Growth	-64.12%	69.18%	-32.45%	-28.62%	25.01%	197.41%
Accounts Receivable	-	188.16	186.58	210.08	163.59	181.04
Receivables	-	188.16	186.58	210.08	163.59	181.04
Inventory	-	507.23	455.71	361.7	346.8	325.38
Prepaid Expenses	-	3.17	1.87	1.23	-	1.17
Other Current Assets	-	36.23	49.18	61.42	59.03	26.17
Total Current Assets	-	790.38	726.2	683.06	637.56	588.26
Property, Plant & Equipment	-	588.46	544.7	491.04	385.15	337.85
Long-Term Investments	-	347.91	285.48	156.69	40.31	-
Other Intangible Assets	-	1.22	0.95	0.85	1.05	0.92
Other Long-Term Assets	-	19.11	12.93	13.52	16.85	80.12
Total Assets	-	1,747	1,570	1,345	1,081	1,007
Accounts Payable	-	52.17	33.68	55.5	41.6	37.14
Accrued Expenses	-	72.46	66.46	55.51	39.37	39.02
Short-Term Debt	-	19.18	67.18	67	64.5	82.85
Current Portion of Long-Term Debt	-	-	-	-	-	11.96
Current Portion of Leases	-	8.9	8.83	3.81	2.9	2.5
Current Income Taxes Payable	-	-	-	0.29	3.14	3.57
Other Current Liabilities	-	24.66	19.56	21.41	17.99	15.75
Total Current Liabilities	-	177.36	195.71	203.51	169.49	192.8
Long-Term Debt	-	1.84	4.53	2.99	10.81	48.55
Long-Term Leases	-	2.35	6.94	11.32	11.09	13.98
Pension & Post-Retirement Benefits	-	16.28	14.83	16.15	14.33	13.17
Long-Term Deferred Tax Liabilities	-	15.21	13.72	12.07	12.76	13.89
Total Liabilities	-	213.04	235.74	246.04	218.47	282.4
Common Stock	-	82.64	82.64	82.64	82.64	82.64
Additional Paid-In Capital	-	86.75	86.75	86.75	86.75	86.75
Retained Earnings	-	1,361	1,162	928.21	692.17	517.02
Comprehensive Income & Other	-	3.99	3.26	1.51	0.89	1.18
Total Common Equity	1,664	1,534	1,335	1,099	862.44	687.58
Minority Interest	-	-	-	-	-	37.18
Shareholders' Equity	1,664	1,534	1,335	1,099	862.44	724.76
Total Liabilities & Equity	-	1,747	1,570	1,345	1,081	1,007
Total Debt	88.5	32.27	87.48	85.12	89.3	159.85
Net Cash (Debt)	-52.51	23.31	-54.63	-36.48	-21.16	-105.35
Net Cash Per Share	-6.35	2.82	-6.61	-4.41	-2.56	-12.75
Filing Date Shares Outstanding	8.26	8.26	8.26	8.26	8.26	8.26
Total Common Shares Outstanding	8.26	8.26	8.26	8.26	8.26	8.26
Working Capital	-	613.02	530.49	479.55	468.06	395.47
Book Value Per Share	201.46	185.64	161.49	133.00	104.36	83.21
Tangible Book Value	1,663	1,533	1,334	1,098	861.4	686.66
Tangible Book Value Per Share	201.33	185.49	161.38	132.90	104.24	83.09
Buildings	-	218.37	207.56	130.34	130.25	135.06
Machinery	-	474.05	391.37	281.77	254.21	236.79
Construction In Progress	-	16.84	25.32	132.94	36.34	2.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.